Weedie


Home / Newswire

v1.0.0
Home
Stocks
Warrants
Heatmap
Newswire
Shorts
Halts
Licenses

Weedstocks Newswire Feed

Weedstocks news RSS feed

Phivida Holdings Retains NATIONAL Equicom for Investor Relations Services

2018-09-06 12:00:31

TORONTO, Sept. 6, 2018 /CNW/ - Phivida Holdings Inc. (CSE: VIDA OTCQX: PHVAF) ("Phivida") is pleased to announce that it has retained NATIONAL Equicom to provide investor relations and financial communications services.

"As we execute on our strategy to introduce exciting new and healthy food and beverage products, it's important that we also raise awareness with both investors and consumers in the U.S. and Canadian markets," said Jim Bailey, President and CEO of Phivida Holdings Inc. "We look forward to partnering with NATIONAL as we continue to expand our story to an even broader customer base."

NATIONAL Equicom will be providing comprehensive services comprising of investor relations, corporate communications, strategic counsel and investor outreach for Phivida based on a monthly retainer fee of C$10,000. Neither NATIONAL Equicom nor any of its principals have an ownership interest, directly or indirectly, in Phivida or its securities, and the Company has not granted NATIONAL Equicom or its principals any right to acquire such interests.

NATIONAL Equicom is one of Canada's largest and most experienced investor relations firms. In addition to a large and growing roster of hemp and cannabis clients, NATIONAL provides investor relations support as well as litigation, crisis and CEO communications to clients in all business sectors, including financial services, healthcare, retail, resources and industrial services, among others.

ABOUT Phivida Holdings Inc. Phivida Holdings Inc. is headquartered in Vancouver, BC with operations in San Diego CA. Phivida is a premium functional food and beverage company focused on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses organic active hemp extract into a variety of premium foods, beverages and clinical products for everyday health. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages, and a focus on holistic health and wellness. The mission is to help reduce the world's dependence on pharmaceuticals and provide food and beverage choices that allow customers to live a balanced healthy lifestyle. For more information, visit phivida.com

...

Read more


NewBridge Global Ventures, Inc. CEO Mark Mersman will be Panelist at the 2018 Texas Traders Convention

2018-09-06 12:00:00

Panel on New Alternative Investments Discussion: Beverage, Tobacco and Cannabis being held on Friday, September 7th at 5:15 pm CDT

Orem, Utah, Sept. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NewBridge Global Ventures, Inc. (“NewBridge” or the “Company”), (OTCQB: NBGV), a company focused on the emerging and dynamic legal and regulated cannabis industry, today announced that it will be a featured panelist at the 2018 Texas Traders Convention, sponsored by the Dallas Security Traders Association. The conference is being held on September 6th – 8th at The Four Seasons Resort at Las Colinas, Dallas, Texas.

Mark Mersman, CEO of Newbridge Global Ventures, will be a panelist on the New Alternative Investments Discussion #2: Beverage, Tobacco and Cannabis on Friday, September 7th at 5:15 pm CDT.

The panel is being moderated by Nick Colas, Co-Founder, Data Trek Research. Other panelists include Dan S. Ahrens, Portfolio Manager, AdvisorShares Vice ETF and Vivien Azer, Beverage, Tobacco, and Cannabis Analyst, Cowen and Company.

About The Dallas Security Traders Association

...

Read more


WeedMD Signs Supply Agreement with the Ontario Cannabis Retail Corporation

2018-09-06 11:35:00

TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company) a federally-licensed producer and distributor of cannabis, is pleased to announce that it has entered into a supply agreement with the Ontario Cannabis Retail Corporation (“OCRC”), operating as the Ontario Cannabis Store (“OCS”) to supply branded cannabis products to the adult-use market in the Province of Ontario.

Under the agreement, the Company will initially supply its cannabis products for online sales via the OCS and will expand to supply Ontario’s private retailers once the province implements an approved framework.

“As a leading Ontario licensed producer, we’re thrilled to announce that adult consumers in our home province will have access to our trusted, medical-grade cannabis strains and products this fall,” said Keith Merker, Chief Executive Officer of WeedMD. “This counts as a significant milestone for WeedMD as it advances our strategic plan to develop a national distribution network at optimal price points to ensure the Company’s medical and adult-use products are available from coast-to-coast.”

The agreement with the OCRC is the fifth supply agreement signed by WeedMD. In addition to Ontario, the Company has signed agreements with the Alberta Gaming, Liquor & Cannabis Commission (AGLC), the British Columbia Liquor Distribution Branch (BC LDB), the Nova Scotia Liquor Corporation (NSLC) and Shoppers Drug Mart1. Additionally, WeedMD continues to be engaged in advanced discussions with other provincial liquor boards and emerging private retail operators.

For more information, access our investor presentation here and corporate video here.

...

Read more


UPDATE: Emblem signs five-year supply agreement with Compass Cannabis Clinic for Starbuds Canada

2018-09-06 11:26:19

Emblem brands and products to be distributed through Compass’ national retail operations, Starbuds Canada

TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), announced today that it has entered into a five-year supply and preferred vendor agreement (the “Agreement”) with 10330698 Canada Ltd. d/b/a Compass Cannabis Clinic (“Compass”) to become a preferred cannabis supplier through its wholly owned subsidiary adult-use retail entity Starbuds Canada (“Starbuds”), effective October 17, 2018.

Compass currently has forty confirmed leases for locations across Canada, a mix of operational clinics that are now open, in development, or in preparation with the intended use of becoming retail cannabis stores. Starbuds – licensee of the Starbuds brand name for Canada from Starbuds based out of Denver, Colorado – has an aggressive expansion plan across Ontario, British Columbia, Alberta and Saskatchewan to serve cannabis enthusiasts across Canada. A wholly-owned subsidiary of Compass, Starbuds has received a cannabis retail license or a conditional license in two provinces along with a dozen retail development permits across the province of Alberta.

Under the Agreement, subject to the receipt by Compass of all required licensing under the applicable provincial cannabis regimes, and where such agreements are permitted by applicable provincial regulations, Emblem will supply Compass with high-quality cannabis, beginning with products under Emblem’s first adult-use brand, Symbl. It is expected that Emblem’s Symbl-branded products will be sold in all provinces in which Compass operates and where Emblem has received a provincial listing or approval for sale.

“Emblem’s relationship with Compass establishes another important distribution channel to get our products and brands to cannabis consumers across Canada. As we continue to build our brands and innovate with products, the retail environment will play a critical role in building our awareness with consumers and driving market share,” said Nick Dean, CEO, Emblem Corp. “Compass is a highly regarded, trusted operator of cannabis clinics, and we are confident their Starbuds retail operations will continue in this vein. As the cannabis retail environment continues to develop, Emblem intends to pursue strategic relationships with retailers that will focus on providing a premier retail experience including product education, customer service, and quality products.”

...

Read more


Former British American Tobacco Senior Executive Joins LGC Capital

2018-09-06 11:00:05

/NOT FOR DISTRIBUTION IN THE UNITED STATES/

Symbol: TSX-V: LG

MONTREAL, Sept. 6, 2018 /CNW Telbec/ - LGC Capital Ltd. (TSXV: LG) ("LGC") is pleased to announce that Mr Remy Di Meglio, a Swiss based, former senior tobacco executive, has joined LGC as a senior advisor.

Mr Di Meglio, brings extensive experience to the LGC team and its investee companies from the global tobacco sector, having served 27 years with British American Tobacco with last 10 years as:

Mazen Haddad, Co-Chairman of LGC Capital stated: "We are pleased that a senior tobacco executive of Mr Di Meglio's caliber has decided to join our dynamic team as a senior advisor to the board. Revenue growth from LGC's fast growing global footprint is of key importance as we expand our legal cannabis growing and sales operations in Europe, Canada, the Caribbean, Australia and beyond. Mr Di Meglio will prove invaluable to the Company by assisting many of our operations with global branding, sales strategies and securing key customers, as we expand our product ranges. Mr Di Meglio can provide immediate assistance to Viridi-Unit in Switzerland that is already selling legal CBD cigarettes into the Swiss market.  His high-level management expertise will also significantly strengthen our future negotiations with new commercial partners."

...

Read more


Auxly and Delta 9 Announce Strategic Investment and Supply Agreement

2018-09-06 11:00:00

VANCOUVER, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX:CBWTF) ("Auxly") and Delta 9 Cannabis Inc. (TSX.V -NINE) (“Delta 9”) are pleased to announce that the parties have entered into definitive agreement (the “Agreement”) whereby Auxly will make a strategic investment to fund the expansion of Delta 9’s licensed cannabis cultivation facility in Winnipeg, Manitoba (the “Facility”) and provide general working capital to Delta 9.

Pursuant to the Agreement, Auxly has subscribed for 5,909,090 common shares of Delta 9 (each a “Delta 9 Share”) at a price of $2.75 per Delta 9 Share, representing a total investment of $16,250,000. In exchange, Auxly will receive the right to purchase a fixed amount of dried cannabis and cannabis trim from the Facility and its expansion for a period of 10 years. Effective January 1, 2019 and until January 1, 2029, Auxly will have the right to purchase 1,000 kilograms of dried cannabis per annum as well as 100 kilograms of cannabis trim. In addition, effective July 1, 2020 and until July 1, 2030, Auxly will have the right to purchase an additional 4,000 kilograms per annum as well as 400 kilograms of cannabis trim.

Auxly and Delta 9 will jointly work to negotiate and enter into a supply agreement for the creation and supply of certain value-added cannabis products from Auxly’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”) as well as a retail collaboration agreement whereby the parties will pursue various retail collaboration opportunities.

Hugo Alves, President of Auxly, commented, “As the Auxly platform has matured, so have the depth of our relationships and the caliber of our partnerships. Today, we are incredibly pleased to be announcing this strategic partnership with Delta 9, a high-quality cannabis operator we have admired since the early days of medical cannabis legalization. We believe this partnership provides an incredible opportunity for us to collaborate to affirm our commitments to our medical patients but also to work together to develop a robust retail platform for the recreational market across Canada. We look forward to working with John and his team at Delta 9 as we move into legalization.”

John Arbuthnot, Chief Executive Officer of Delta 9, commented, “This financing and strategic agreement is one more piece of the puzzle for our company as we prepare for legalization in Canada, and our upcoming expansion into Canadian and international markets. The Auxly subscription follows the recent Delta 9 announcement of a loan agreement with a Tier 1 Canadian chartered bank for $12,000,000, and the $23,000,000 prospectus financing in December 2017. We are now well funded not only for our current phase of expansion through 2019 but have a war chest we can use to seize new opportunities that Delta 9 has been working on for several months. Our partners at Auxly are leaders in the global cannabis industry, and among the most knowledgeable and influential companies in the space. We feel the partnership will be of great benefit to Delta 9, to Auxly, and to the subsidiaries that Auxly owns.”

...

Read more


Emerald Health Therapeutics Announces Amendment from Health Canada for Pure Sunfarms’ Cultivation License, Expanding Cannabis Production Area to Approximately 550,000 Square Feet in One of the Single Largest Cannabis Growing Facilities in the World

2018-09-06 11:00:00

Entire first half of 1.1 million square foot Delta 3 greenhouse now approved for cultivation and sale

VICTORIA, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) and Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTC: VFFIF) today announced that their 50/50 joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada its fourth amendment to the cultivation license for its Delta 3 greenhouse in Delta, BC. This amendment permits Pure Sunfarms to expand its cannabis production area to 550,000 square feet – half of the 1.1 million square foot Delta 3 production facility. The newly licensed area is expected to be in full production by mid-October of this year.

“It’s a remarkable achievement to now have 550,000 square feet – half of the 1.1 million square foot Delta 3 facility – approved for production just six months since receiving the initial cultivation license,” said Michael DeGiglio, CEO of Village Farms. “I am tremendously proud of the Pure Sunfarms team.”

“Pure Sunfarms is making great strides to achieve high-quality, low-cost cannabis production ahead of the Canadian government’s legalization of adult-use cannabis on October 17,” said Chris Wagner, CEO of Emerald.

In July, Pure Sunfarms received its sales license from Health Canada, permitting it to sell cannabis produced in the Delta 3 greenhouse facility. Pure Sunfarms expects to have the full 1.1 million square foot Delta 3 facility, one of the single largest cannabis growing facilities in the world, converted for cannabis production by year end. The technologically-advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 17 grow rooms (nine of which are now licensed) optimized for year-round harvesting (more than 85 harvests annually) and an automated process line encompassing harvesting, trimming, drying and packaging.

...

Read more


Emblem signs five-year supply agreement with Compass Cannabis Clinic for Starbuds Canada

2018-09-06 10:30:00

Emblem brands and products to be distributed through Compass’ national retail operations, Starbuds Canada

TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), announced today that it has entered into a five-year supply and preferred vendor agreement (the “Agreement”) with 10330698 Canada Ltd. d/b/a Compass Cannabis Clinic (“Compass”) to become a preferred cannabis supplier through its wholly owned subsidiary adult-use retail entity Starbuds Canada (“Starbuds”), effective October 17, 2018.

Compass currently has forty confirmed leases for locations across Canada, a mix of operational clinics that are now open, in development, or in preparation with the intended use of becoming retail cannabis stores. Starbuds – licensee of the Starbuds brand name for Canada from Starbuds based out of Denver, Colorado – has an aggressive expansion plan across Ontario, British Columbia, Alberta and Saskatchewan to serve cannabis enthusiasts across Canada. A wholly-owned subsidiary of Compass, Starbuds has received cannabis retail licenses in two provinces along with a dozen retail development permits across the province of Alberta.

Under the Agreement, subject to the receipt by Compass of all required licensing under the applicable provincial cannabis regimes, and where such agreements are permitted by applicable provincial regulations, Emblem will supply Compass with high-quality cannabis, beginning with products under Emblem’s first adult-use brand, Symbl. It is expected that Emblem’s Symbl-branded products will be sold in all provinces in which Compass operates and where Emblem has received a provincial listing or approval for sale.

“Emblem’s relationship with Compass establishes another important distribution channel to get our products and brands to cannabis consumers across Canada. As we continue to build our brands and innovate with products, the retail environment will play a critical role in building our awareness with consumers and driving market share,” said Nick Dean, CEO, Emblem Corp. “Compass is a highly regarded, trusted operator of cannabis clinics, and we are confident their Starbuds retail operations will continue in this vein. As the cannabis retail environment continues to develop, Emblem intends to pursue strategic relationships with retailers that will focus on providing a premier retail experience including product education, customer service, and quality products.”

...

Read more


Tilray® Selected by Prince Edward Island Cannabis Management Corporation to Supply Adult-Use Cannabis

2018-09-06 10:30:00

Products will be available on Prince Edward Island starting Oct. 17, 2018

TORONTO--(BUSINESS WIRE)--Tilray Canada Ltd. (“Tilray”), a wholly owned subsidiary of Tilray, Inc. (Nasdaq: TLRY), announced today that it has received a purchase order from the Prince Edward Island Cannabis Management Corporation (“PEICMC”) for adult-use cannabis. The purchase order will allow Tilray to supply the province of Prince Edward Island’s four cannabis stores and online channels with cannabis products in anticipation of the launch of the adult-use market on October 17, 2018. Tilray intends to fulfill PEICMC purchase orders through its affiliate High Park Holdings Ltd., DBA High Park Company™ (“High Park”), which was formed to produce and distribute a broad-based portfolio of adult-use cannabis brands and products.

“We’re thrilled High Park will have the opportunity to expand our national reach and grow our retail network by supplying Prince Edward Island’s four cannabis stores with a safe, secure and reliable source of adult-use cannabis products,” said Adine Fabiani-Carter, Chief Marketing Officer at High Park. “Our intention is to deliver on the expectations the people of P.E.I. have of us by cultivating and distributing a selection of products that will lead the market in quality, excellence and craftsmanship.”

The High Park portfolio is uniquely crafted and grown by master horticulturists dedicated to sustainable growing practices. Select products will be made available on Prince Edward Island through retail stores starting October 17, 2018, the anticipated date of launch for adult-use cannabis products on Prince Edward Island.

...

Read more


Cannabis Growth Opportunity Corporation Releases NAV and Special Meeting of Shareholders

2018-09-06 09:00:49

Next CGOC investor webinar on September 11, 2018

TORONTO, Sept. 6, 2018 /CNW/ - Cannabis Growth Opportunity Corporation (CSE: CGOC), a cannabis focused investment corporation with both public and private cannabis holdings, today announced the company's updated net asset value per common share (NAV) was $2.66 at the close of business on September 4, 2018, a growth of 16.6 percent since August 13, 2018.

The Company is also pleased to announce that it will hold a special meeting of shareholders on October 15, 2018. At the meeting, shareholders will be asked to consider and, if deemed appropriate, to approve removing some of the investment restrictions including, but not limited to, restrictions prohibiting the Company from investing more than 40% of its total assets in securities of private issuers and investing more than 10% of its total assets in securities of any single issuer.  A copy of the management information circular, which will include full details of the proposed changes, will be mailed to shareholders of record as of the close of business on September 14, 2018 and will be posted on CGOC's SEDAR profile at www.sedar.com.

CGOC is now over 95 percent invested in companies operating in Canada, the US, Jamaica and Israel. Information about the company's holdings is available at www.cgocorp.com.  CGOC's top ten public investments as of September 4, 2018 (in alphabetical order) are: C21 Investments, Canopy Growth, Indiva Ltd., HEXO Corp., Organigram, Plant 13, Solo Growth, Sunniva, Valens GroWorks and Vivo Cannabis. These holdings represent 41.8 percent of the company's overall portfolio. CGOC's private investments represent approximately 44 percent (under 40% at cost) of the overall portfolio and have not been marked up since July 3, 2018.

CGOC will host it's next webinar on Tuesday, September 11 at 4:30 pm EDT during which company executives will discuss the rationale for the special shareholders meeting, CGOC's performance, and an update on both the public and private holdings. The webinar will be co-hosted by Jamie Blundell, President and Chief Operating Officer of CGOC, and Bruce Campbell, Chief Investment Officer. Interested webinar attendees can register at www.cgocorp.com/investors/.

...

Read more